Cargando…

An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration

BACKGROUND: The study aimed to investigate the pharmacokinetics of intravenous ciprofloxacin and the adequacy of 400 mg every 12 hours in critically ill Intensive Care Unit (ICU) patients on continuous veno-venous haemodiafiltration (CVVHDF) with particular reference to the effect of achieved flow r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spooner, Almath M, Deegan, Catherine, D'Arcy, Deirdre M, Gowing, Caitriona M, Donnelly, Maria B, Corrigan, Owen I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161942/ https://www.ncbi.nlm.nih.gov/pubmed/21816053 http://dx.doi.org/10.1186/1472-6904-11-11

Ejemplares similares

An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration
por: D’Arcy, Deirdre M, et al.
Publicado: (2012)

A pharmacokinetic basis for improving therapeutic outcomes of aminoglycoside therapy during continuous venovenous haemodiafiltration
por: Spooner, A, et al.
Publicado: (2007)

Linezolid pharmacokinetics in critically ill patients with renal replacement therapy: comparison of equi-dose of continuous veno-venous haemofiltration with continuous veno-venous haemodiafiltration
por: Roger, C, et al.
Publicado: (2015)

The immunological effects of continuous veno-venous haemodiafiltration in critically ill patients
por: Toft, Palle, et al.
Publicado: (1999)

Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous haemodiafiltration (CVVHDF)
por: Kirwan, Marcus, et al.
Publicado: (2021)

Early veno-venous haemodiafiltration for sepsis-related multiple organ failure
por: Page, Bernard, et al.
Publicado: (2005)

Amikacin Pharmacokinetics During Continuous Veno-Venous Hemodialysis
por: Lam, Simon W., et al.
Publicado: (2013)

Levetiracetam Pharmacokinetics in a Patient with Intracranial Hemorrhage Undergoing Continuous Veno-Venous Hemofiltration
por: Van Matre, Edward T., et al.
Publicado: (2017)

Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation
por: Mariat, Christophe, et al.
Publicado: (2006)

How continuous is continuous veno-venous haemofiltration?
por: Seidel, J, et al.
Publicado: (2006)

Valproic acid overdose and continuous venovenous haemodiafiltration
por: Jacobs, Frédéric M., et al.
Publicado: (2008)

Elimination of linezolid in patients undergoing low-flow continuous venovenous haemodiafiltration
por: Ide, T, et al.
Publicado: (2012)

Meropenem pharmacokinetics in critically ill patients with or without burn treated with or without continuous veno‐venous haemofiltration
por: Selig, Daniel J., et al.
Publicado: (2021)

Variations of veno-arterial and mucosal-arterial CO(2) gap during continuous veno-venous hemodiafiltration
por: Chagnon, J-L, et al.
Publicado: (1998)

Catheter Port Reversal in Citrate Continuous Veno-Venous Hemofiltration
por: Boer, Willem, et al.
Publicado: (2021)

Clinical evidence on haemodiafiltration
por: Blankestijn, Peter J, et al.
Publicado: (2018)

The effect of continuous veno-venous haemofiltration on PiCCO(® )haemodynamic parameters
por: Mason, N, et al.
Publicado: (2005)

Continuous veno-venous hemofiltration in patients with metformin associated lactic acidosis
por: Bethlehem, C, et al.
Publicado: (2015)

Effectiveness of continuous veno-venous hemofiltration in the treatment of severe acute pancreatitis
por: Chen, Xuan, et al.
Publicado: (2019)

402 Pharmacokinetics of Extended vs Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration
por: Frippiat, Frédéric, et al.
Publicado: (2014)

CONVINCE in the context of existing evidence on haemodiafiltration
por: Vernooij, Robin W M, et al.
Publicado: (2022)

Haemodiafiltration—optimal efficiency and safety
por: Ledebo, Ingrid, et al.
Publicado: (2010)

Hybrid renal replacement techniques vs continuous haemodiafiltration in haemodynamically unstable patients
por: Marcelino, P, et al.
Publicado: (2006)

Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: a prospective randomized controlled trial
por: Weidhase, Lorenz, et al.
Publicado: (2020)

Fundamentals of weaning veno-arterial and veno-venous extracorporeal membrane oxygenation
por: Tsiouris, Athanasios, et al.
Publicado: (2023)

Changes in Plasma Kynurenic Acid Concentration in Septic Shock Patients Undergoing Continuous Veno-Venous Haemofiltration
por: Dabrowski, Wojciech, et al.
Publicado: (2013)

Treatment of Ventilator-associated Pneumonia with High-dose Colistin Under Continuous Veno-venous Hemofiltration
por: Spapen, Herbert, et al.
Publicado: (2019)

The efficacy of haemoperfusion combined with continuous venovenous haemodiafiltration in the treatment of severe viral encephalitis in children
por: Zhao, Jun-Lin, et al.
Publicado: (2023)

Ciprofloxacin Pharmacokinetics in Clinical Canine Patients
por: Papich, M.G.
Publicado: (2017)

Impaired Pharmacokinetics of Amiodarone under Veno-Venous Extracorporeal Membrane Oxygenation: From Bench to Bedside
por: Lescroart, Mickaël, et al.
Publicado: (2022)

Impact of daytime continuous veno-venous haemofiltration on treatment of paediatric tumour lysis syndrome
por: Wang, Yamei, et al.
Publicado: (2018)

The Pharmacokinetics of The Biliary Excretion of Ciprofloxacin
por: Ball, C. S., et al.
Publicado: (1989)

Efficacy of continuous haemodiafiltration using a polymethylmethacrylate membrane haemofilter in the treatment of sepsis and acute respiratory distress syndrome
por: Sakai, M
Publicado: (2012)

Pharmacokinetics and Pharmacodynamics of Anti-infective Agents during Continuous Veno-venous Hemofiltration in Critically Ill Patients: Lessons Learned from an Ancillary Study of the IVOIRE Trial
por: Breilh, Dominique, et al.
Publicado: (2019)

Case Report: Monitoring Vancomycin Concentrations and Pharmacokinetic Parameters in Continuous Veno-Venous Hemofiltration Patients to Guide Individualized Dosage Regimens: A Case Analysis
por: Chen, Jihui, et al.
Publicado: (2021)

Pharmacokinetics of Teicoplanin in a Patient with Coronavirus Disease 2019 Receiving Veno-venous Extracorporeal Membrane Oxygenation
por: Hirayu, Nobuhisa, et al.
Publicado: (2022)

Successful Use of Continuous Veno-Venous Haemodialysis in a Case of Potential Lethal Caffeine Intoxication
por: Reimerink, Elles J., et al.
Publicado: (2023)

Comparison of pre-filter and post-filter ionised calcium monitoring in continuous veno-venous hemodiafiltration (CVVHD-F) with citrate anti-coagulation
por: Brain, Matthew J., et al.
Publicado: (2017)

Use of Multifrequency Bioimpedance Analysis in Male Patients with Acute Kidney Injury Who Are Undergoing Continuous Veno-Venous Hemodiafiltration
por: Rhee, Harin, et al.
Publicado: (2015)

Corticosteroids combined with continuous veno-venous hemodiafiltration for treatment of hantavirus pulmonary syndrome caused by Puumala virus infection
por: Seitsonen, E., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_4fpend1g49p9rlf2e6ste6o2a5